(CIDRAP News) Albany Medical College in Albany, N.Y., has received an $8.3 million federal grant to study pulmonary tularemia, with the main emphasis on developing a vaccine, college officials announced last week.
The grant from the National Institute of Allergy and Infectious Diseases (NIAID) will fund tularemia research at the college for 4½ years, the college said in a news release.
(CIDRAP News) – The British biotechnology company Acambis announced yesterday that it has launched the first clinical trial of its vaccine for West Nile virus, called ChimeriVax-West Nile.
The phase 1 trial will involve 60 adult volunteers in Lenexa, Kan., the company said in a news release. The volunteers will receive one of three doses of the West Nile vaccine or a licensed yellow fever vaccine that is being used as a control.
(CIDRAP News) A team of researchers in St. Louis has retooled a mousepox virus so it can defeat a vaccine that normally protects micebut has also found ways to beat the customized virus, according to the group's leader.
(CIDRAP News) The federal government awarded two contracts totaling more than $150 million this week for further testing and initial production of new anthrax vaccines designed to be safer and require fewer doses than the existing vaccine.
(CIDRAP News) Federal health officials yesterday announced grants to build 11 new biodefense laboratories around the country, including two that will be authorized to study the most dangerous pathogens.
(CIDRAP News) Federal health officials yesterday released a 37-page report that they say demonstrates "tremendous progress" in developing countermeasures for bioterrorism through federally funded research since early 2002.
(CIDRAP News) In response to criticism from smallpox expert Dr. D. A. Henderson, the senior author of a recent study on smallpox immunity has defended his group's conclusion that a single smallpox shot may provide at least some protection for decades or even for life.
(CIDRAP News) – The US Department of Health and Human Services yesterday announced $350 million in grants for eight regional centers to lead and coordinate research on defenses against bioterrorism and emerging infectious diseases.
(CIDRAP News) As the number of West Nile virus cases continues to climb, the National Institute of Allergy and Infectious Diseases (NIAID) announced that its scientists have created a promising new vaccine against the virus. The vaccine involves a distantly related virus, dengue type 4, in which some proteins have been replaced by corresponding proteins from the West Nile virus.
(CIDRAP News) – Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have determined that a single injection of a fast-acting experimental Ebola vaccine confers protection against the disease in monkeys after just 1 month.